Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study

OBJECTIVE: This surveillance study was conducted to verify the post-market safety and effectiveness of bevacizumab, which was approved in Japan in 2013 for the treatment of patients with newly diagnosed and or recurrent malignant glioma. METHODS: This was a prospective, observational, multicenter po...

Descripción completa

Detalles Bibliográficos
Autores principales: Motoo, Nagane, Hayashi, Yasuko, Shimizu, Ayaka, Ura, Masako, Nishikawa, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923818/
https://www.ncbi.nlm.nih.gov/pubmed/31665343
http://dx.doi.org/10.1093/jjco/hyz125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923818/
https://www.ncbi.nlm.nih.gov/pubmed/31665343
http://dx.doi.org/10.1093/jjco/hyz125

Ejemplares similares